文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

[A novel therapeutic approach to bone replacement: vitalisation of industrial processed allogenic bone graft with autologous bone marrow].

作者信息

Schmid U, Thielemann F, Weise K, Ochs B G

机构信息

Vulpiusklinik Bad Rappenau, Akademisches Lehrkrankenhaus der Universität Heidelberg, Fachklinik für Orthopädie, Orthopädische Chirurgie, Handchirurgie, Bad Rappenau.

出版信息

Z Orthop Unfall. 2007 Mar-Apr;145(2):221-9. doi: 10.1055/s-2007-965204.


DOI:10.1055/s-2007-965204
PMID:17492564
Abstract

AIM: Osseous defects of the human skeleton are a common problem in reconstructive orthopaedic and trauma surgery. In spite of a long-standing history of research on different organic and inorganic bone replacement materials, a clinically applicable alternative to autogenous bone transplants has not been found. METHODS: The current paper describes a novel bone replacement material, which is vitalised through injection of autologous bone marrow. Industrially processed bone allografts were used for bone replacement; the cancellous bone graft was gained from femoral heads from living human donors and processed by a French tissue bank (Banque de Tissus France, TBF). Sterile packed allogenic bone grafts can be stored at room temperature, are easy to handle and can be adapted to almost every bone defect due to their stability and versatility. RESULTS: From July 2003 to February 2006 125 patients,70 men and 55 women, underwent bone grafting with composite transplants composed of autogenous marrow cells and industrial processed bone allografts. The average age at surgery was 62 (14-84) years; the follow-up period was 11 months. The indication to use the allograft included the whole spectrum of bony defects conventionally treated with autologous cancellous bone grafts such as primary and revision surgery in THA (n = 64) and the treatment of pseudarthrosis particularly of the lower limb (n = 30). CONCLUSION: In comparison to current bone replacement materials applied in clinical use, this approach promises to replicate the biomechanical and biological properties of autogenous cancellous bone. This is an important advantage over conventional approaches to ensure successful healing and regeneration of bone defects. Hence application of vitalised bone allograft represents an important alternative to conventional autogenous cancellous bone which avoids certain complications associated with harvesting and transplantation of autogenous bone. This applies in particular in situations in which harvesting of autogenous cancellous bone is not or no longer possible.

摘要

相似文献

[1]
[A novel therapeutic approach to bone replacement: vitalisation of industrial processed allogenic bone graft with autologous bone marrow].

Z Orthop Unfall. 2007

[2]
Fibula and tibia fusion with cancellous allograft vitalised with autologous bone marrow: first results for infected tibial non-union.

Arch Orthop Trauma Surg. 2009-1

[3]
[Treatment of traumatic bone defect with graft material of allogenic cancellous combined with autologous red marrow].

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2008-10

[4]
[Bone grafts in hip prosthesis revisions].

Acta Chir Orthop Traumatol Cech. 2003

[5]
Bone marrow/allograft component therapy. A clinical trial.

Am J Orthop (Belle Mead NJ). 1995-1

[6]
The outcome of composite bone graft substitute used to treat cavitary bone defects.

Orthopedics. 2008-8

[7]
[Reconstruction of the acetabulum during replacement of the aseptically loosened polyethylene cup].

Acta Chir Orthop Traumatol Cech. 2001

[8]
[Use of bioactive glass ceramics in the treatment of tibial plateau fractures].

Acta Chir Orthop Traumatol Cech. 2002

[9]
Bone replacement grafts. The bone substitutes.

Dent Clin North Am. 1998-7

[10]
Comparison of bone grafts for posterior spinal fusion in adolescent idiopathic scoliosis.

Spine (Phila Pa 1976). 2003-4-15

引用本文的文献

[1]
Current evidence on potential of adipose derived stem cells to enhance bone regeneration and future projection.

World J Stem Cells. 2021-9-26

[2]
First mid-term results after cancellous allograft vitalized with autologous bone marrow for infected femoral non-union.

Wien Klin Wochenschr. 2016-11

[3]
Concise review: the clinical application of mesenchymal stem cells for musculoskeletal regeneration: current status and perspectives.

Stem Cells Transl Med. 2012-2-22

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索